1. Use of a pharmaceutical combination of an angiotensin-converting enzyme and pineal hormone for separate parallel and / or sequential administration for the treatment of ischemic heart disease in elderly patients, characterized in that as an inhibitor of angiotensin-converting enzyme fosinopril used, and as the pineal hormone used melatonin, and the normalization of the status of elderly patients going 3-4 den.2. Use according to Claim. 1, wherein the fosinopril is administered at a dose of 10 mg 2 times a sutki.3. Use according to claim. 1 wherein the melatonin is administered in a dose of 1 mg 3 times a sutki.4. Use according to claim. 3, wherein the melatonin is administered within 30 minutes before sleep.
展开▼